Troy Cox, Michael Pellini

Foundation Medicine announced that it has appointed Troy Cox as CEO to succeed Michael Pellini, who has been appointed as chairman of the board of directors. Pellini replaces Alexis Borisy, who will continue to serve on the board. Cox joins Foundation Medicine from Roche-Genentech, where he led one of the largest oncology portfolios in the US. Before joining Genentech, he held leadership positions at UCB BioPharma, Sanofi-Aventis, and Schering-Plough.


Philip Bourne

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.